NASDAQ:DNLI - Denali Therapeutics Inc.
$25.17
 $-1.03
-3.93%
4:00PM EDT
2019-04-18
Denali Therapeutics Inc., incorporated on October 14, 2013 is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected approximately three specific pathways that are implicated as triggers or effectors of neurodegeneration, including degenogenes (genes that cause neurodegenerative disease when mutated), defective intracellular trafficking, glial dysfunction and axon degeneration. The Companys development programs include Lysosomal Function Pathway, Glial Biology Pathway, and Cellular Homeostasis Pathway. Its product pipeline includes drug candidates such as DNL201, DNL 151, ATV:aSyn, ETV:IDS, DNL747, ATV:TREM2, and ATV:BACE1/Tau. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  DNLI     avg for
industry   		  avg for
sector  
42 stocks weight:  0. 10   203. 85   241. 91  
42 stocks rank:  4. 29 K 1. 44 K 1. 05 K
# analyst opinions:  5. 00   14. 51   13. 97  
mean recommendation:  2. 40   2. 09   2. 01  
quick ratio:  14. 42   5. 27   1. 81  
current ratio:  14. 67   5. 62   2. 25  
target price low:  $ 22. 00   $ 84. 80   $ 115. 21  
target price avg:  $ 27. 20   $ 111. 51   $ 137. 51  
target price high:  $ 33. 00   $ 135. 81   $ 157. 84  
1-yr high:  $ 28. 14   $ 114. 23   $ 138. 78  
last close:  $ 25. 17   $ 87. 66   $ 116. 69  
50-day avg:  $ 22. 93   $ 95. 54   $ 123. 44  
200-day avg:  $ 19. 10   $ 94. 25   $ 121. 11  
1-yr low:  $ 12. 46   $ 72. 78   $ 98. 34  
volume:  472. 72 K 4. 11 M 8. 07 M
50-day avg volume:  426. 77 K 2. 76 M 5. 02 M
200-day avg volume:  445. 91 K 2. 92 M 4. 59 M
1-day return:  -3. 93 % -0. 41 % 0. 07 %
this week return:  -9. 75 % -5. 74 % -4. 11 %
12-wk return:  15. 19 % 1. 61 % -0. 05 %
52-wk return:  34. 70 % 3. 12 % 8. 78 %
enterprise value (EV):  $ 1. 93 B $ 48. 94 B $ 114. 64 B
market cap:  $ 2. 40 B $ 43. 07 B $ 104. 73 B
EBITDA:  $ -37. 06 M $ 4. 45 B $ 8. 01 B
enterprise multiple (EV/EBITDA):  -52. 19   4. 22   12. 73  
enterprise/revenue (EV/R):  14. 97   63. 17   12. 84  
total revenue:  $ 129. 16 M $ 10. 62 B $ 38. 47 B
total debt:  $ 0. 00   $ 12. 24 B $ 16. 73 B
net income (common):  $ -36. 24 M $ 2. 20 B $ 4. 20 B
shares outstanding:  95. 29 M 571. 70 M 1. 24 B
shares:  47. 45 M 571. 81 M 1. 23 B
shares short:  9. 49 M 10. 17 M 13. 00 M
shares short prior month:  9. 35 M 9. 54 M 17. 33 M
short ratio:  20. 05   5. 41   3. 28  
short % of float:  17. 55 % 5. 45 % 2. 38 %
total cash/share:  $ 4. 87   $ 11. 14   $ 9. 33  
total cash:  $ 464. 30 M $ 6. 71 B $ 7. 15 B
free cash flow:  $ 482. 00 K $ 3. 58 B $ 2. 96 B
operating cash flow:  $ 50. 12 M $ 4. 15 B $ 4. 30 B
book value:  $ 5. 78   $ 12. 78   $ 26. 92  
price/book:  4. 36   3. 06   -1. 74  
gross profits:  $ -12. 12 M $ 8. 04 B $ 34. 86 B
operating margins:  -34. 43 % -725. 35 % -89. 04 %
EBITDA margins:  -28. 69 % 10. 94 % 22. 51 %
profit margins:  -28. 06 % 7. 81 % 10. 57 %
gross margins:  -9. 39 % 37. 08 % 55. 70 %
1-yr max volatility:  12. 85 % --- ---
1-yr mean volatility:  0. 17 % 0. 03 % 0. 04 %
1-yr EPS:  -0. 39   2. 40   4. 10  
forward EPS:  -1. 63   3. 97   7. 13  
P/E:  -64. 37   13. 63   22. 72  
forward P/E:  -15. 44   -15. 95   13. 99  
PE/G:  83. 86   -1. 65   -1. 32  
growth:  -0. 77 % 127. 12 % 29. 61 %
earnings high:  $ -0. 18   $ 1. 00   $ 1. 66  
earnings avg:  $ -0. 40   $ 0. 77   $ 1. 53  
earnings low:  $ -0. 48   $ 0. 50   $ 1. 39  
revenue high:  $ 36. 00 M $ 2. 68 B $ 10. 78 B
revenue avg:  $ 9. 12 M $ 2. 59 B $ 10. 57 B
revenue low:  $ 640. 00 K $ 2. 49 B $ 10. 36 B
return on assets:  -4. 84 % -2. 75 % 4. 55 %
return on equity:  -7. 16 % -18. 45 % 5. 46 %
revenue/share:  1. 39   13. 29   55. 46  
beta (1yr vs S&P500):  1. 71   1. 25   0. 93  
sharpe (1yr):  0. 70   0. 37   0. 70  
held % insiders:  9. 18 % 6. 39 % 3. 38 %
held % institutions:  84. 37 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : DNLI
.    + 4.626 =         4.626 :: INITIAL WEIGHT
.   + 37.367 =        41.993 :: inverse volume-to-price addition
.   + 37.405 =        79.398 :: spline projection addition
.    x 5.757 =       457.078 :: 13 weeks' performance factor
.    x 1.307 =       597.334 :: one-year gains+dividend factor
.    x 1.431 =       855.038 :: industry recommendation factor
.    x 1.512 =      1293.232 :: symbol recommendation factor
.    x 1.237 =       1599.78 :: EV/R factor
.      x 1.0 =      1599.006 :: return on assets factor
.    x 0.999 =      1597.862 :: return on equity factor
.    x 2.608 =       4166.65 :: current ratio factor
.    x 1.037 =      4319.079 :: quick ratio factor
.    x 1.025 =      4425.476 :: short ratio factor
.    x 2.044 =      9043.767 :: price-to-book factor
.    x 1.396 =     12625.299 :: 5-day avg > 200-day avg
.    x 1.163 =     14678.353 :: 5-day avg > 50-day avg
.    x 1.201 =     17625.198 :: 50-day avg > 200-day avg
.    x 1.021 =     17991.521 :: P/E weight
.     x 0.33 =      5945.369 :: PE/G factor
.    x 1.393 =      8283.666 :: beta factor
.    x 0.702 =      5817.431 :: sharpe factor
.    x 0.965 =      5610.979 :: target low factor
.    x 1.095 =      6142.137 :: target mean factor
.    x 1.056 =      6484.715 :: target high factor
.     x 1.31 =      8494.249 :: industry 2-weeks return factor
.    x 0.925 =      7856.906 :: "drift" penalty 5 days ago
.    x 0.964 =      7573.046 :: overall "drift" factor
.    x 0.871 =      6599.593 :: largest single-day jump factor
.     x 1.01 =      6665.478 :: mean volatility factor
.    x 1.097 =      7311.601 :: 42-day mean volatility factor
.      x 1.0 =      7310.414 :: factor hist industry gain for week 16
.   cubeRoot =        19.408 :: reduced to standardize
.    - 20.35 =         0.097 :: add/subtract for performance
.                      0.097 :: FINAL WEIGHT for NASDAQ:DNLI

 

News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org